Cargando…
High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis
BACKGROUND: ACE2 a key molecule of the Renin-Angiotensin system has been identified as the receptor for SARS-CoV-2 entry into human cells. In the context of human cancers, there is evidence that ACE2 might function as a tumor suppressor. The expression levels of ACE2 among the different subtypes of...
Autores principales: | Nair, Madhumathy G, Prabhu, Jyothi S, TS, Sridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825889/ https://www.ncbi.nlm.nih.gov/pubmed/33517235 http://dx.doi.org/10.1016/j.ctarc.2021.100321 |
Ejemplares similares
-
Data on alteration of hormone and growth factor receptor profiles over progressive passages of breast cancer cell lines representing different clinical subtypes
por: Nair, Madhumathy G., et al.
Publicado: (2016) -
miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
por: Nair, Madhumathy G, et al.
Publicado: (2020) -
High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers
por: Desai, Krisha, et al.
Publicado: (2016) -
miR-18a Mediates Immune Evasion in ER-Positive Breast Cancer through Wnt Signaling
por: Nair, Madhumathy G., et al.
Publicado: (2022) -
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease
por: Prabhu, Jyothi S, et al.
Publicado: (2017)